This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 101 No. 2 February 1998, pp. 313-314

AMERICAN ACADEMY OF PEDIATRICS:
Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus

Sections on Endocrinology and Ophthalmology

The first 20% of the full text of this article appears below.

    BACKGROUND

Diabetic retinopathy, a specific vascular complication of diabetes mellitus, is the leading cause of new cases of legal blindness in patients 20 to 74 years of age in the United States. The prevalence of retinopathy is related directly to the duration of diabetes. Nearly all patients with type 1 diabetes mellitus eventually develop some degree of retinopathy.1 Two forms of diabetes are recognized: type 1 (insulin-dependent) and type 2 (noninsulin-dependent). Patients with type 1 diabetes have a higher risk of developing severe proliferative retinopathy leading to visual loss.2-5

    PURPOSE

The primary purpose of this statement is to establish an evaluation schedule that provides optimal preventive care and management for pediatric patients with type 1 diabetes mellitus.

    GOALS

1.  Identify the pediatric patient at . . . [Full Text of this Article]
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

The following policy statement is a revision:

Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus
, , and
Pediatrics 116: 270-273. [Full Text]



This article has been cited by other articles:


Home page
 PediatricsHome page
G. T. Lueder, J. Silverstein, and and Section on Ophthalmology and Section on Endocr
Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus
Pediatrics, July 1, 2005; 116(1): 270 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Maguire, A. Chan, J. Cusumano, S. Hing, M. Craig, M. Silink, N. Howard, and K. Donaghue
The Case for Biennial Retinopathy Screening in Children and Adolescents
Diabetes Care, March 1, 2005; 28(3): 509 - 513.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Silverstein, G. Klingensmith, K. Copeland, L. Plotnick, F. Kaufman, L. Laffel, L. Deeb, M. Grey, B. Anderson, L. A. Holzmeister, et al.
Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association
Diabetes Care, January 1, 2005; 28(1): 186 - 212.
[Full Text] [PDF]